Suppression of Recurrent Ventricular Fibrillation Associated with J-Wave Syndrome Using Cilostazol

Sudden cardiac death (SCD) survivors should be carefully evaluated for primary electrical diseases of the heart, including early repolarization syndrome (ERS). Early repolarization patterns in some patients may be hindered by depolarization or intermittent, making it difficult to diagnose. Besides implantable cardioverter defibrillator (ICD) implantation for secondary prevention, pharmacological agents like quinidine and phosphodiesterase-III inhibitors (e.g., cilostazol) are recommended to prevent or reduce recurrent VF episodes. We presented an SCD survivor, a young female patient with a documented VF and ICD implantation, who was admitted after Home Monitoring detected multiple short-coupled PVC-induced VF episodes and was successfully treated with cilostazol.